Introduction
A tiny, very polar molecule with one nitrogen atom bound to three hydrogen atoms is ammonia (NH3). A covalent bond forms between the nitrogen and hydrogen atoms when they share electrons. As a possible hydrogen-bond donor, NH3 has one lone pair of electrons on the nitrogen atom.
Nevertheless, compared with more linearly arranged molecules, its pyramidal shape makes it a less effective hydrogen-bond donor. By interacting with compounds that can donate hydrogen atoms, NH3 may function as a hydrogen-bond acceptor. The polar character of NH3 and the existence of this lone pair make it soluble in water, which makes it easy for it to establish hydrogen bonds with water molecules.
Role of Glutamine and Alanine in Ammonia Movement in the Body
Because ammonia is poisonous in excess, its movement through the body is essential. The organism uses the amino acids glutamine and alanine as carriers rather than releasing NH3 into circulation. Because of their unique properties, certain amino acids are ideal for this function.
Both glutamine and alanine are hydrophilic and neutral because of their amide side chains (Benz et al., 2021). The former forms a stable amide bond with ammonia thanks to the nitrogen in its side chain. In contrast, alanine may be formed by reacting with ammonia. The next step is for the kidneys to excrete glutamate and alanine, which can then be safely delivered to the liver for conversion into urea.
It is possible to deduce that glutamine and alanine are good ammonia transporters from their structures. The former is polar and may generate hydrogen bonds because its side chain contains an amide group. Alanine shows nonpolarity due to its simple methyl side chain.
They both contain a core carbon (alpha carbon) joined to an amino group, a carboxyl group, a hydrogen atom, and a variable side chain (Elfsmark et al., 2022). While alanine has a methyl group as its R-group, glutamine has an amide side chain. In contrast to glutamine, whose polar amide side chain enables interactions with water, alanine is hydrophobic due to its nonpolar side chain.
Beyond their function as ammonia transporters, glutamine and alanine play important roles in metabolism. In several metabolic pathways, it is an essential nitrogen donor; it is involved in the production of pyrimidines, purines, and nucleotides (Gioia et al., 2021). Gluconeogenesis can convert alanine into glucose because it is a glucogenic amino acid. The fact that certain amino acids can serve two purposes demonstrates their versatility in supporting basic metabolic functions.
Ammonia metabolism relies on glutaminase, an enzyme that catalyzes the transformation of glutamine into glutamate and ammonia. In the liver, this process is crucial for excreting ammonia via the urea cycle. In this process, glutamate is produced by hydrolysis of the amide bond in glutamine, releasing ammonia (Benz et al., 2021). The process begins with glutamine and water as reactants and ends with glutamate and ammonia as products. In addition to ensuring that ammonia can be transported safely, this mechanism also provides a vital substrate for the urea cycle, which, in turn, prevents the buildup of harmful levels of ammonia in the body.
Conclusion
Thus, ammonia is carried throughout the body as amino acids, specifically glutamine and alanine. These amino acids are ideal ammonia transporters due to their metabolic properties, structures, and R-groups. The role of glutaminase in facilitating the conversion of glutamine underscores the importance of these amino acids in ammonia metabolism and, more broadly, in metabolic processes. Amino acid homeostasis and the prevention of amino acid toxicity are intricately related processes, and the body’s complex use of amino acids as transporters exemplifies this.
References
Benz, D. C., Ferro, P., Safa, N., Messerli, M., von Felten, E., Huang, W., Patriki, D., Giannopoulos, A. A., Fuchs, T. A., Gräni, C., Gebhard, C., Pazhenkottil, A. P., Kaufmann, P. A., & Buechel, R. R. (2021). Role of quantitative myocardial blood flow and 13N-ammonia washout for viability assessment in ischemic cardiomyopathy. Journal of Nuclear Cardiology, 28(1), 263–273.
Elfsmark, L., Ågren, L., Akfur, C., & Jonasson, S. (2022). Ammonia exposure by intratracheal instillation causes severe and deteriorating lung injury and vascular effects in mice. Inhalation Toxicology, 34(5–6), 145–158.
Gioia, S., Ridola, L., Cristofaro, L., Merli, M., Faccioli, J., Riggio, O., & Nardelli, S. (2021). The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Liver International, 41(12), 2965–2973.